50 results
DEF 14C
SCNX
Scienture Holdings, Inc.
28 Aug 24
Information statement
4:05pm
of Delaware, which provides that any action that may be taken at any annual or special meeting of stockholders may be taken without a meeting, without prior … or a special meeting of the stockholders, and not by written consent, by the affirmative vote of at least 66 2/3 percent of the outstanding voting stock
PRE 14C
SCNX
Scienture Holdings, Inc.
15 Aug 24
Preliminary information
9:57pm
, which provides that any action that may be taken at any annual or special meeting of stockholders may be taken without a meeting, without prior notice … by our Board and authorized at an annual or a special meeting of the stockholders, and not by written consent, by the affirmative vote of at least 66 2/3
8-K
EX-99.1
SCNX
Scienture Holdings, Inc.
13 Oct 23
Superlatus Announces Distribution Partnership with North America’s Leading Wholesale Distributor and Expanded Points of Retail Sales
1:25pm
business after its next special meeting of stockholders. For more information on TRxADE, please visit the Company’s IR website
PRER14A
isy4 ryh1gopbl
8 Sep 23
Preliminary revised proxy
10:42am
8-K
f9fav szuwuz10q
21 Dec 22
Submission of Matters to a Vote of Security Holders
4:30pm
424B3
ew1hqnree2pov
8 Dec 22
Prospectus supplement
5:05pm
PRE 14A
a9dl4xpjzpch
24 Oct 22
Preliminary proxy
5:29pm
8-K
yc95sraq2pgij8lv
7 Oct 22
TRxADE Health Announces Pricing of $1.8 Million Registered Direct Offering
4:50pm
8-K
EX-10.1
jpmpdqb4
7 Oct 22
TRxADE Health Announces Pricing of $1.8 Million Registered Direct Offering
4:50pm
424B5
n0c9tpquqpr7 zk6y
6 Oct 22
Prospectus supplement for primary offering
5:28pm
424B5
ys5hwn87
23 Aug 22
Prospectus supplement for primary offering
4:01pm